301408 华人健康
午间休市 09-23 11:30:00
资讯
新帖
简况
华人健康（301408）新增【医美】概念
证券之星 · 09-03
华人健康（301408）新增【医美】概念
闯关7亿定增：华人健康IPO募投频繁改道，12.8亿商誉高悬
市场资讯 · 08-31
闯关7亿定增：华人健康IPO募投频繁改道，12.8亿商誉高悬
华人健康（301408）2026年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-29
华人健康（301408）2026年中报简析：营收净利润同比双双增长，盈利能力上升
华人健康（301408）披露2026年半年度报告，8月28日股价下跌1.33%
证券之星 · 08-28
华人健康（301408）披露2026年半年度报告，8月28日股价下跌1.33%
华人健康(301408)7月20日股东户数3.22万户，较上期增加10.64%
证券之星 · 08-28
华人健康(301408)7月20日股东户数3.22万户，较上期增加10.64%
股市必读：华人健康新发布《第五届董事会第十六次会议决议公告》
证券之星 · 08-28
股市必读：华人健康新发布《第五届董事会第十六次会议决议公告》
图解华人健康中报：第二季度单季净利润同比增长33.03%
证券之星 · 08-28
图解华人健康中报：第二季度单季净利润同比增长33.03%
华人健康：医药营销板块已实现落地应用
证券之星 · 08-18
华人健康：医药营销板块已实现落地应用
华人健康：代理奥利司他胶囊、排毒清脂胶囊
证券之星 · 08-18
华人健康：代理奥利司他胶囊、排毒清脂胶囊
华人健康IPO资金未用完再启7亿定增：商誉高悬减值压力持续攀升 机构股东集体减持离场
新浪证券 · 08-14
华人健康IPO资金未用完再启7亿定增：商誉高悬减值压力持续攀升 机构股东集体减持离场
华人健康：公司以医药产业为核心，构建医药零售、医药营销、终端集采、研发生产四位一体、科学布局的产业生态
证券之星 · 08-12
华人健康：公司以医药产业为核心，构建医药零售、医药营销、终端集采、研发生产四位一体、科学布局的产业生态
股市必读：华人健康新发布《第五届董事会第十五次会议决议公告》
证券之星 · 08-12
股市必读：华人健康新发布《第五届董事会第十五次会议决议公告》
华人健康：AI技术主要应用于门店运营领域
证券之星 · 08-11
华人健康：AI技术主要应用于门店运营领域
华人健康（301408）披露2026年度向特定对象发行A股股票预案，8月11日股价上涨2.77%
证券之星 · 08-11
华人健康（301408）披露2026年度向特定对象发行A股股票预案，8月11日股价上涨2.77%
华人健康：持续践行仿创结合的研发战略
证券之星 · 08-11
华人健康：持续践行仿创结合的研发战略
华人健康最新公告：拟定增募资不超7.09亿元投建智能制造等项目
证券之星 · 08-10
华人健康最新公告：拟定增募资不超7.09亿元投建智能制造等项目
华人健康拟通过A股定向增发募资不超过7.091亿元，用于项目投资及补充流动资金
美股速递 · 08-10
华人健康拟通过A股定向增发募资不超过7.091亿元，用于项目投资及补充流动资金
股市必读：华人健康新发布《关于全资子公司收到药品注册受理通知书的公告》
证券之星 · 08-10
股市必读：华人健康新发布《关于全资子公司收到药品注册受理通知书的公告》
华人健康：全资子公司琥珀酸亚铁片药品注册申请获受理
格隆汇 · 08-09
华人健康：全资子公司琥珀酸亚铁片药品注册申请获受理
华人健康新提交“鸿方”、“固恒健”等2件商标注册申请
证券之星 · 08-07
华人健康新提交“鸿方”、“固恒健”等2件商标注册申请
加载更多
公司概况
公司名称：
安徽华人健康医药股份有限公司
所属行业：
零售业
上市日期：
2023-03-01
主营业务：
安徽华人健康医药股份有限公司的主营业务是医药零售、医药营销、终端集采、研发生产。公司的主要产品是中西成药、中药饮片、保健品、医疗器械、原料药。
发行价格：
16.24
{"stockData":{"symbol":"301408","market":"SZ","secType":"STK","nameCN":"华人健康","latestPrice":15.17,"timestamp":1790134200000,"preClose":15.56,"halted":0,"volume":9300300,"delay":0,"changeRate":-0.0251,"floatShares":229000000,"shares":400000000,"eps":0.5588,"marketStatus":"午间休市","change":-0.39,"latestTime":"09-23 11:30:00","open":15.66,"high":15.72,"low":15.1,"amount":142000000,"amplitude":0.0398,"askPrice":15.19,"askSize":40,"bidPrice":15.17,"bidSize":40,"shortable":0,"etf":0,"ttmEps":0.5588,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790139600000},"marketStatusCode":3,"adr":0,"adjPreClose":15.56,"symbolType":"stock","openAndCloseTimeList":[[1790127000000,1790134200000],[1790139600000,1790146800000]],"highLimit":17.12,"lowLimit":14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":400010000,"isCdr":false,"pbRate":2.94,"roa":"--","peRate":27.147459,"roe":"6.31%","epsLYR":0.48,"committee":0.525622,"marketValue":6068000000,"turnoverRate":0.0406,"status":1,"floatMarketCap":3473000000},"requestUrl":"/m/hq/s/301408","defaultTab":"news","newsList":[{"id":"2664874767","title":"华人健康（301408）新增【医美】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874767","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664874767?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:30","pubTimestamp":1788438625,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，9月3日华人健康新增概念。新增概念原因：2026年6月25日公告：近日，全资子公司江苏神华药业有限公司收到国家药品监督管理局签发的米诺地尔搽剂《药品注册证书》。华人健康主营业务：从事医药代理、零售及终端集采三大块业务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300039096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663246020","title":"闯关7亿定增：华人健康IPO募投频繁改道，12.8亿商誉高悬","url":"https://stock-news.laohu8.com/highlight/detail?id=2663246020","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663246020?lang=zh_cn&edition=full","pubTime":"2026-08-31 12:41","pubTimestamp":1788151260,"startTime":"0","endTime":"0","summary":"值得关注的是，在推进新一轮股权融资的当下，华人健康IPO阶段募集资金并未完全消耗。募投两度改道据了解，华人健康IPO阶段，将自建直营门店作为营销网络建设项目的核心路径。回到华人健康这一个案，本次7.09亿元定增方案推出之时，IPO募集资金尚有结余，同时方案设置1.5亿元补充流动资金，市场由此关注本次再融资的资金必要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-31/doc-iniqetnt4650485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4127","FRHC","IPOS","REDS","KCE","BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016225","title":"华人健康（301408）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016225?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:52","pubTimestamp":1787957558,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华人健康发布2026年中报。截至本报告期末，公司营业总收入28.25亿元，同比上升12.81%，归母净利润1.36亿元，同比上升31.01%。本报告期华人健康盈利能力上升，毛利率同比增幅3.89%，净利率同比增幅17.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900013241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062719","title":"华人健康（301408）披露2026年半年度报告，8月28日股价下跌1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662062719?lang=zh_cn&edition=full","pubTime":"2026-08-28 19:13","pubTimestamp":1787915637,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，华人健康报收于14.88元，较前一交易日下跌1.33%，最新总市值为59.52亿元。报告期内，公司实现营业收入2,824,690,091.29元，同比增长12.81%；归属于上市公司股东的净利润为135,908,900.86元，同比增长31.01%；扣除非经常性损益后的净利润为132,056,760.71元，同比增长31.00%。报告期末，公司总资产为5,468,260,909.33元，较上年度末下降0.37%；归属于上市公司股东的净资产为2,118,892,308.38元，较上年度末增长1.05%。公司控股股东及实际控制人在报告期内未发生变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800044674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662606951","title":"华人健康(301408)7月20日股东户数3.22万户，较上期增加10.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662606951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662606951?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:57","pubTimestamp":1787911046,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华人健康披露，截至2026年7月20日公司股东户数为3.22万户，较6月30日增加3098.0户，增幅为10.64%。在医药商业行业个股中，华人健康股东户数低于行业平均水平，截至7月20日，医药商业行业平均股东户数为4.45万户。从股价来看，2026年6月30日至2026年7月20日，华人健康区间涨幅为3.48%，在此期间股东户数增加3098.0户，增幅为10.64%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603550","title":"股市必读：华人健康新发布《第五届董事会第十六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662603550?lang=zh_cn&edition=full","pubTime":"2026-08-28 05:08","pubTimestamp":1787864895,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司自2026年1月1日起执行《企业会计准则解释第20号》，本次会计政策变更无需提交董事会和股东会审议，不产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662851080","title":"图解华人健康中报：第二季度单季净利润同比增长33.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662851080","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662851080?lang=zh_cn&edition=full","pubTime":"2026-08-28 03:04","pubTimestamp":1787857443,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康2026年中报显示，上半年度公司主营收入28.25亿元，同比上升12.81%；归母净利润1.36亿元，同比上升31.01%；扣非净利润1.32亿元，同比上升31.0%；其中2026年第二季度，公司单季度主营收入14.04亿元，同比上升13.47%；单季度归母净利润5656.54万元，同比上升33.03%；单季度扣非净利润5414.98万元，同比上升31.73%；负债率60.25%，投资收益169.84万元，财务费用1530.01万元，毛利率34.72%。财报数据概要请见下图:本文数据来源于华人健康2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800006252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660671714","title":"华人健康：医药营销板块已实现落地应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2660671714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660671714?lang=zh_cn&edition=full","pubTime":"2026-08-18 20:51","pubTimestamp":1787057492,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康08月17日在投资者关系平台上答复投资者关心的问题。医药营销板块已实现落地应用，上线商城智能推荐系统，依托算法实现商品精准推送，提升转化效率；终端集采板块相关 AI 应用正在布局推进中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800039883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK1515","BK1574","BK1161","301408","159938","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660538474","title":"华人健康：代理奥利司他胶囊、排毒清脂胶囊","url":"https://stock-news.laohu8.com/highlight/detail?id=2660538474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660538474?lang=zh_cn&edition=full","pubTime":"2026-08-18 08:36","pubTimestamp":1787013371,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康(301408)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：华人健康有代理减肥药销售吗？华人健康回复：尊敬的投资者，您好！公司代理业务板块相关减重产品有奥利司他胶囊、排毒清脂胶囊。买药、用药请遵医嘱或咨询执业医师、执业药师。上述药品销售预计不会对公司业绩产生重大影响。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800007370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659197145","title":"华人健康IPO资金未用完再启7亿定增：商誉高悬减值压力持续攀升 机构股东集体减持离场","url":"https://stock-news.laohu8.com/highlight/detail?id=2659197145","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659197145?lang=zh_cn&edition=full","pubTime":"2026-08-14 12:03","pubTimestamp":1786680180,"startTime":"0","endTime":"0","summary":"华人健康未来能否持续抵御行业性毛利率下滑压力，仍有待观察。2025年阿里健康实施大额减持，套现规模约1.2亿元，持股比例降至5%以下，后续减持无需持续公告。赛富投资旗下多家机构同样密集减持。截至2026年4月末，赛富投资已累计减持400万股。华泰紫金旗下华泰大健康一号基金减持力度更大。2026年一季度，华泰大健康一号基金已退出前十大股东名单。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-08-14/doc-ininhaiq4219507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301408","IPOS","BK4127","FRHC","REDS","KCE","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658500924","title":"华人健康：公司以医药产业为核心，构建医药零售、医药营销、终端集采、研发生产四位一体、科学布局的产业生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2658500924","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658500924?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:03","pubTimestamp":1786518195,"startTime":"0","endTime":"0","summary":"公司以医药产业为核心，构建医药零售、医药营销、终端集采、研发生产四位一体、科学布局的产业生态，持续深化工业端产品与终端渠道协同发展。门诊统筹、商保直付是零售药店重要发展方向，公司持续推动符合条件的门店完成资质对接与业务开通，稳步拓展门店覆盖范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200020331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1574","09939","BK1515","BK0209","159938","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658391252","title":"股市必读：华人健康新发布《第五届董事会第十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658391252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658391252?lang=zh_cn&edition=full","pubTime":"2026-08-12 00:58","pubTimestamp":1786467490,"startTime":"0","endTime":"0","summary":"利润分配方案需经董事会审议后提交股东大会通过。关于本次向特定对象发行A股股票预案披露的提示性公告安徽华人健康医药股份有限公司于2026年8月10日召开第五届董事会第十五次会议，审议通过了关于公司2026年度向特定对象发行A股股票的相关议案。本次发行事项尚需经公司股东大会审议、深圳证券交易所审核及中国证监会注册，公告提示该事项未构成实质性判断或批准，提醒投资者注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658286918","title":"华人健康：AI技术主要应用于门店运营领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2658286918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658286918?lang=zh_cn&edition=full","pubTime":"2026-08-11 20:48","pubTimestamp":1786452501,"startTime":"0","endTime":"0","summary":"公司目前 AI 技术主要应用于门店运营领域，正规划有关医药零售、智能审方、供应链管理等业务场景，由数字化到数智化转型升级落地；同时在药品研发环节引入 AI 赋能，如立项阶段智能分析流行病、临床及专利数据，研判市场格局并提供专利规避思路；开发阶段辅助制剂处方工艺设计，同步评估技术壁垒等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100035597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996991","title":"华人健康（301408）披露2026年度向特定对象发行A股股票预案，8月11日股价上涨2.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996991","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996991?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:26","pubTimestamp":1786440414,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，华人健康报收于16.3元，较前一交易日上涨2.77%，最新总市值为65.2亿元。该股当日开盘15.56元，最高17.3元，最低15.55元，成交额达6.29亿元，换手率为16.66%。近日，安徽华人健康医药股份有限公司披露《2026年度向特定对象发行A股股票预案》，拟向特定对象发行A股股票，募集资金总额不超过70,907.43万元，用于智能制造与分拣中心项目、医药研发项目、信息化建设项目及补充流动资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100027762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399300","BK0209","301408","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658872995","title":"华人健康：持续践行仿创结合的研发战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2658872995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658872995?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:36","pubTimestamp":1786437375,"startTime":"0","endTime":"0","summary":"仿制药与创新药之间的资源分配优先级是怎样的？公司持续践行仿创结合的研发战略，不断优化研发管线结构，立足于中长期发展规划，积极布局改良型新药、创新药及生物药领域，稳步优化管线结构、提升创新类品种占比，并依托正药科技、神华药业推进研发协同。公司实施梯队化管线布局，以高端及成熟仿制药夯实经营基本盘，保障产品持续落地与现金流转化；同步培育改良型新药、创新药、生物药，打造中长期增长动力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100026012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658093954","title":"华人健康最新公告：拟定增募资不超7.09亿元投建智能制造等项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2658093954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658093954?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:40","pubTimestamp":1786365651,"startTime":"0","endTime":"0","summary":"华人健康(301408.SZ)公告称，公司发布2026年度向特定对象发行A股股票预案，拟向不超过35名特定对象发行股票，数量不超过5000万股，募集资金总额不超过7.09亿元，用于智能制造与分拣中心项目、医药研发项目、信息化建设项目及补充流动资金。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000030931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179716724","title":"华人健康拟通过A股定向增发募资不超过7.091亿元，用于项目投资及补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1179716724","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179716724?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:29","pubTimestamp":1786364955,"startTime":"0","endTime":"0","summary":"华人健康（Anhui Huaren Health Pharmaceutical Co., Ltd.）近日宣布，公司计划通过A股非公开发行方式募集资金，总额上限为7.091亿元人民币。这笔资金将主要用于支持公司旗下项目的推进，并补充日常运营所需的资本金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658702616","title":"股市必读：华人健康新发布《关于全资子公司收到药品注册受理通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658702616","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658702616?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:43","pubTimestamp":1786297389,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，华人健康报收于15.54元，上涨2.71%，换手率13.59%，成交量31.13万手，成交额4.77亿元。该药品为抗贫血药物，适用于治疗和预防成人、儿童及孕妇的缺铁性贫血。本次注册申请已获受理，进入审评阶段，但审批结果、获批时间及后续销售情况存在不确定性，对公司短期业绩无重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658743146","title":"华人健康：全资子公司琥珀酸亚铁片药品注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2658743146","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658743146?lang=zh_cn&edition=full","pubTime":"2026-08-09 16:15","pubTimestamp":1786263304,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0209","301408"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657612676","title":"华人健康新提交“鸿方”、“固恒健”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2657612676","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657612676?lang=zh_cn&edition=full","pubTime":"2026-08-07 07:08","pubTimestamp":1786057707,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日安徽华人健康医药股份有限公司新提交“鸿方”、“固恒健”等2件商标注册申请。商标申请详情如下：今年以来安徽华人健康医药股份有限公司新申请注册商标102件，截止目前公司共持有注册商标281件，另有154件商标尚在注册申请中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700006109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790134204421,"stockEarnings":[{"period":"1week","weight":0.13},{"period":"1month","weight":0.0045},{"period":"3month","weight":0.0026},{"period":"6month","weight":-0.0576},{"period":"1year","weight":0.2078},{"period":"ytd","weight":-0.1566}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.012},{"period":"3month","weight":-0.0386},{"period":"6month","weight":0.0162},{"period":"1year","weight":0.0323},{"period":"ytd","weight":-0.0042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽华人健康医药股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"32225人(较上一季度增加10.64%)","perCapita":"7105股","listingDate":"2023-03-01","address":"安徽省合肥市包河区河北路123号","registeredCapital":"40001万元","survey":" 安徽华人健康医药股份有限公司的主营业务是医药零售、医药营销、终端集采、研发生产。公司的主要产品是中西成药、中药饮片、保健品、医疗器械、原料药。","listedPrice":16.24},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华人健康(301408)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华人健康(301408)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华人健康,301408,华人健康股票,华人健康股票老虎,华人健康股票老虎国际,华人健康行情,华人健康股票行情,华人健康股价,华人健康股市,华人健康股票价格,华人健康股票交易,华人健康股票购买,华人健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华人健康(301408)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华人健康(301408)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}